NEWARK, DE | The SGLT2 inhibitors market was valued at USD 17.8 billion in 2025. According to Future Market Insights analysis, the market is estimated to reach USD 18.9 billion in 2026 and expand to USD 34.5 billion by 2036, reflecting a steady compound annual growth rate (CAGR) of 6.2% during the forecast period. This expansion is propelled by guideline-backed adoption in cardiorenal...